These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 6300169

  • 1. Plasma immunoreactive proopiolipomelanocortin-derived peptides in patients with primary hyperaldosteronism, idiopathic hyperaldosteronism with bilateral adrenal hyperplasia, and dexamethasone-suppressible hyperaldosteronism.
    Güllner HG, Nicholson WE, Gill JR, Orth DN.
    J Clin Endocrinol Metab; 1983 Apr; 56(4):853-5. PubMed ID: 6300169
    [Abstract] [Full Text] [Related]

  • 2. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME, Orth DN, Halmi NS, Zielinski AC, Davis DR, Chavez FT, Drucker WD.
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [Abstract] [Full Text] [Related]

  • 3. Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests.
    Orth DN, Holscher MA, Wilson MG, Nicholson WE, Plue RE, Mount CD.
    Endocrinology; 1982 Apr; 110(4):1430-41. PubMed ID: 6277607
    [No Abstract] [Full Text] [Related]

  • 4. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
    Kem DC, Weinberger MH, Gomez-Sanchez C, Higgins JR, Kramer NJ.
    J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
    [Abstract] [Full Text] [Related]

  • 5. Plasma beta-endorphin levels in primary aldosteronism.
    Griffing GT, McIntosh T, Berelowitz B, Hudson M, Salzman R, Manson JA, Melby JC.
    J Clin Endocrinol Metab; 1985 Feb; 60(2):315-9. PubMed ID: 2981243
    [Abstract] [Full Text] [Related]

  • 6. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.
    Wilson MG, Nicholson WE, Holscher MA, Sherrell BJ, Mount CD, Orth DN.
    Endocrinology; 1982 Mar; 110(3):941-54. PubMed ID: 6276164
    [Abstract] [Full Text] [Related]

  • 7. Effects of proopiomelanocortin peptides and angiotensin II on steroidogenesis in isolated aldosteronoma cells.
    Pham-Huu-Trung MT, Bogyo A, de Smitter N, Girard F.
    J Clin Endocrinol Metab; 1985 Sep; 61(3):467-71. PubMed ID: 2991320
    [Abstract] [Full Text] [Related]

  • 8. Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension.
    Griffing GT, Berelowitz B, Hudson M, Salzman R, Manson JA, Aurrechia S, Melby JC, Pedersen RC, Brownie AC.
    J Clin Invest; 1985 Jul; 76(1):163-9. PubMed ID: 4019776
    [Abstract] [Full Text] [Related]

  • 9. Pituitary peptides other than ACTH may not be aldosterone secretagogue in primary aldosteronism.
    Miyamori I, Koshida H, Matsubara T, Soma R, Takasaki H, Okamoto S, Takeda R.
    Exp Clin Endocrinol; 1990 Aug; 95(3):323-9. PubMed ID: 2174003
    [Abstract] [Full Text] [Related]

  • 10. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels.
    Kem DC, Tang K, Hanson CS, Brown RD, Painton R, Weinberger MH, Hollifield JW.
    J Clin Endocrinol Metab; 1985 Jan; 60(1):67-73. PubMed ID: 3964794
    [Abstract] [Full Text] [Related]

  • 11. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
    Chan JS, Lu CL, Seidah NG, Chretien M.
    Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
    [Abstract] [Full Text] [Related]

  • 12. Differential control of the release of pro-opiomelanocortin-derived peptides from the pars intermedia of the rat pituitary. Response to serotonin.
    Randle JC, Moor BC, Kraicer J.
    Neuroendocrinology; 1983 Aug; 37(2):131-40. PubMed ID: 6310431
    [No Abstract] [Full Text] [Related]

  • 13. Identification of pro-opiomelanocortin-derived peptides in the human adrenal medulla.
    Evans CJ, Erdelyi E, Weber E, Barchas JD.
    Science; 1983 Sep 02; 221(4614):957-60. PubMed ID: 6308766
    [Abstract] [Full Text] [Related]

  • 14. Synthetic ovine corticotropin-releasing hormone: simultaneous release of proopiolipomelanocortin peptides in man.
    Jackson RV, DeCherney GS, DeBold CR, Sheldon WR, Alexander AN, Rivier J, Vale W, Orth DN.
    J Clin Endocrinol Metab; 1984 Apr 02; 58(4):740-3. PubMed ID: 6321535
    [Abstract] [Full Text] [Related]

  • 15. Effect of naloxone on the adrenal cortex in primary aldosteronism.
    Fallo F, Boscaro M, Sonino N, Mantero F.
    Am J Hypertens; 1988 Jul 02; 1(3 Pt 1):280-2. PubMed ID: 2839206
    [Abstract] [Full Text] [Related]

  • 16. Responses of isolated guinea-pig adrenal cells to ACTH and pro-opiocortin-derived peptides.
    Pham-Huu-Trung MT, De Smitter N, Bogio A, Bertagna X, Girard F.
    Endocrinology; 1982 May 02; 110(5):1819-21. PubMed ID: 6280975
    [Abstract] [Full Text] [Related]

  • 17. gamma 3-Melanocyte-stimulating hormone immunoreactivity is a component of the neuroendocrine response to maximal stress (cardiac arrest).
    Wortsman J, Frank S, Wehrenberg WB, Petra PH, Murphy JE.
    J Clin Endocrinol Metab; 1985 Aug 02; 61(2):355-60. PubMed ID: 2989321
    [Abstract] [Full Text] [Related]

  • 18. A pituitary tumor producing high molecular weight adrenocorticotropin-related peptides: clinical and cell culture studies.
    Fuller PJ, Lim AT, Barlow JW, White EL, Khalid BA, Copolov DL, Lolait S, Funder JW, Stockigt JR.
    J Clin Endocrinol Metab; 1984 Jan 02; 58(1):134-42. PubMed ID: 6315755
    [Abstract] [Full Text] [Related]

  • 19. Concomitant changes of ACTH, beta-endorphin and N-terminal portion of pro-opiomelanocortin in rats.
    Lis M, Larivière N, Maurice G, Julesz J, Seidah N, chrétien M.
    Life Sci; 1982 Apr 05; 30(14):1159-64. PubMed ID: 6283283
    [Abstract] [Full Text] [Related]

  • 20. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism.
    Guthrie GP.
    J Lab Clin Med; 1981 Sep 05; 98(3):364-73. PubMed ID: 6267148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.